Australia

PARADIGM BIOPHARMACEUTICALS LIMITED.. (PAR)

Track

Track

Paradigm Biopharmaceuticals Limited has recorded no insider trading activity within the last ninety days. The most recent transactions occurred on November 30, 2023, when Helen Fisher and Paul Rennie executed share purchases. Historical data indicates consistent buying patterns from key personnel, though these events date back more than three months.
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for PARADIGM BIOPHARMACEUTICALS LIMITED... Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Helen Fisher Director
Transaction date
Purchase
Price
107.63
Quantity 62,171
Value A$205,245
Paul Rennie Director
Transaction date
Purchase
Price
10.50
Quantity 85,272
Value A$3,064,333
Helen Fisher Director
Transaction date
Purchase
Price
451.96
Quantity 4,575
Value A$919,777
Paul Rennie Director
Transaction date
Purchase
Price
1.03
Quantity 73,851
Value A$76,001
Paul Rennie Director
Transaction date
Purchase
Price
1.29
Quantity 47,720
Value A$61,521
Paul Rennie Director
Transaction date
Purchase
Price
1.30
Quantity 233,845
Value A$303,999
Donna Skerrett Director
Transaction date
Purchase
Price
1.89
Quantity 375,000
Value A$708,750
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-12-01 2023-11-30 B Purchase Helen Fisher Director
62,171
107.63
A$205,245 		62,171 107.63 A$205,245
2023-11-30 2023-11-30 B Purchase Paul Rennie Director
85,272
10.50
A$3,064,333 		85,272 10.50 A$3,064,333
2023-05-22 2023-05-18 B Purchase Helen Fisher Director
4,575
451.96
A$919,777 		4,575 451.96 A$919,777
2023-05-17 2023-05-12 B Purchase Paul Rennie Director
73,851
1.03
A$76,001 		73,851 1.03 A$76,001
2022-12-22 2022-12-19 B Purchase Paul Rennie Director
47,720
1.29
A$61,521 		47,720 1.29 A$61,521
2022-09-19 2022-09-14 B Purchase Paul Rennie Director
233,845
1.30
A$303,999 		233,845 1.30 A$303,999
2022-02-01 2022-01-25 B Purchase Donna Skerrett Director
375,000
1.89
A$708,750 		375,000 1.89 A$708,750
Explore more

More insider trading research around PARADIGM BIOPHARMACEUTICALS LIMITED..

More insider trades in Australia
Insider trading in Asia-Pacific